Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 22.93% is 11% above its 5-year average of 20.58%, near the low end of its 5-year range (11.20%–120.60%).
3.37% below its 12-month average of 23.73%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 22.65%.
NET PROFIT MARGIN
22.93%
NET PROFIT MARGIN AVG TTM
23.73%
NET PROFIT MARGIN AVG 3Y
22.65%
NET PROFIT MARGIN AVG 5Y
20.58%
NET PROFIT MARGIN AVG 10Y
17.64%
NET PROFIT MARGIN AVG 15Y
17.09%
NET PROFIT MARGIN AVG 20Y
17.56%
CURRENT VS TTM AVG
-3.37%
CURRENT VS 3Y AVG
+1.24%
CURRENT VS 5Y AVG
+11.41%
CURRENT VS 10Y AVG
+29.99%
CURRENT VS 15Y AVG
+34.19%
CURRENT VS 20Y AVG
+30.59%
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+164.17%
vs the sector median at left
Market Cap
$243.44B
Net Profit Margin
17.02%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$242.75B
Net Profit Margin
15.06%
TTM Avg
14.95%
3Y Avg
14.84%
5Y Avg
16.47%
Market Cap
$332.18B
Net Profit Margin
20.33%
TTM Avg
16.80%
3Y Avg
17.87%
5Y Avg
19.70%
Market Cap
$338.13B
Net Profit Margin
3.14%
TTM Avg
3.15%
3Y Avg
4.63%
5Y Avg
5.09%
Market Cap
$356.05B
Net Profit Margin
4.78%
TTM Avg
27.40%
3Y Avg
19.98%
5Y Avg
20.62%
Market Cap
$179.66B
Net Profit Margin
-10.64%
TTM Avg
15.29%
3Y Avg
17.07%
5Y Avg
15.27%
Market Cap
$168.54B
Net Profit Margin
11.65%
TTM Avg
23.34%
3Y Avg
19.20%
5Y Avg
17.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novartis AG (NVS) | $267.96B | 22.93% | 23.73% | 22.65% | 20.58% |
| AstraZeneca PLC (AZN)vs › | $243.44B | 17.02% | 15.23% | 12.72% | 10.53% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $242.75B | 15.06% | 14.95% | 14.84% | 16.47% |
| Amgen Inc. (AMGN)vs › | $217.61B | 22.93% | 16.61% | 20.49% | 22.20% |
| Roche Holding AG (RHHBY)vs › | $332.18B | 20.33% | 16.80% | 17.87% | 19.70% |
| UnitedHealth Group Incorporated (UNH)vs › | $338.13B | 3.14% | 3.15% | 4.63% | 5.09% |
| Merck & Co., Inc. (MRK)vs › | $356.05B | 4.78% | 27.40% | 19.98% | 20.62% |
| Gilead Sciences, Inc. (GILD)vs › | $179.66B | -10.64% | 15.29% | 17.07% | 15.27% |
| Abbott Laboratories (ABT)vs › | $168.54B | 11.65% | 23.34% | 19.20% | 17.71% |
| Novo Nordisk A/S (NVO)vs › | $165.79B | 35.33% | 33.96% | 33.83% | 33.74% |
Operating Margin
30.5%
Net Profit Margin
22.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 22.65% |
| 2026-03-31 | 23.34% |
| 2025-12-31 | 18.06% |
| 2025-09-29 | 27.36% |
| 2025-06-30 | 27.24% |
| 2025-03-31 | 26.48% |
| 2024-12-31 | 20.78% |
| 2024-09-30 | 24.21% |
| 2024-06-30 | 25.22% |
| 2024-03-31 | 22.18% |
| 2023-12-31 | 72.01% |
| 2023-09-30 | 14.56% |
| 2023-06-30 | 19.72% |
| 2023-03-31 | 20.76% |
| 2022-12-31 | 11.20% |
| 2022-09-30 | 14.59% |
| 2022-06-30 | 12.95% |
| 2022-03-31 | 17.34% |
| 2021-12-31 | 120.60% |
| 2021-09-30 | 20.63% |
| 2021-06-30 | 21.78% |
| 2021-03-31 | 16.22% |
| 2020-12-31 | 16.07% |
| 2020-09-30 | 15.43% |
| 2020-06-30 | 16.06% |
| 2020-03-31 | 17.12% |
| 2019-12-31 | 8.85% |
| 2019-09-30 | 16.36% |
| 2019-06-30 | 56.55% |
| 2019-03-31 | 15.42% |
| 2018-12-31 | 8.75% |
| 2018-09-30 | 14.25% |
| 2018-06-30 | 66.66% |
| 2018-03-31 | 18.14% |
| 2017-12-31 | 15.01% |
| 2017-09-30 | 16.40% |
| 2017-06-30 | 15.85% |
| 2017-03-31 | 14.14% |
| 2016-12-31 | 7.59% |
| 2016-09-30 | 15.72% |
| 2016-06-30 | 14.23% |
| 2016-03-31 | 17.03% |
| 2015-12-31 | 8.23% |
| 2015-09-30 | 15.12% |
| 2015-06-30 | 14.24% |
| 2015-03-31 | 106.58% |
| 2014-12-31 | 11.17% |
| 2014-09-30 | 24.23% |
| 2014-06-30 | 18.32% |
| 2014-03-31 | 22.57% |
| 2013-12-31 | 13.21% |
| 2013-09-30 | 17.29% |
| 2013-06-30 | 18.95% |
| 2013-03-31 | 16.88% |
| 2012-12-31 | 13.57% |
| 2012-09-30 | 17.02% |
| 2012-06-30 | 18.21% |
| 2012-03-31 | 16.15% |
| 2011-12-31 | 7.84% |
| 2011-09-30 | 16.39% |
| 2011-06-30 | 17.88% |
| 2011-03-31 | 19.48% |
| 2010-12-31 | 15.00% |
| 2010-09-30 | 17.75% |
| 2010-06-30 | 20.28% |
| 2010-03-31 | 23.74% |
| 2009-12-31 | 17.54% |
| 2009-09-30 | 18.58% |
| 2009-06-30 | 18.94% |
| 2009-03-31 | 19.77% |
| 2008-12-31 | 14.87% |
| 2008-09-30 | 18.95% |
| 2008-06-30 | 20.46% |
| 2008-03-31 | 22.68% |
| 2007-12-31 | 8.89% |
| 2007-09-30 | 69.92% |
| 2007-06-30 | 21.36% |
| 2007-03-31 | 23.14% |
| 2006-12-31 | 17.75% |
| 2006-09-30 | 20.69% |
| 2006-06-30 | 20.06% |
| 2006-03-31 | 23.89% |
| 2005-12-31 | 15.42% |
| 2005-09-30 | 19.54% |
| 2005-06-30 | 20.91% |
| 2005-03-31 | 20.17% |
| 2004-12-31 | 18.18% |
| 2004-09-30 | 21.92% |
| 2004-06-30 | 22.21% |
| 2004-03-31 | 19.48% |
| 2003-12-31 | 20.21% |
| 2003-09-30 | 20.56% |
| 2003-06-30 | 21.22% |
| 2003-03-31 | 18.58% |
| 2002-12-31 | 21.50% |
| 2002-09-30 | 21.96% |
